Clinical Trial Management - software & AI news

Daily news on software, AI, and companies shaping clinical trial management.

Showing 118 results
A minimalist illustration of a clipboard with a checkmark, symbolizing efficient clinical trials.

Oct 13, 2026

IQVIA, Veeva expand on existing partnership for speedier clinical trials

IQVIA and Veeva Systems have announced an enhancement of their partnership aimed at accelerating the efficiency of clinical trials.The updated collaboration incorporates Veeva's suite of trial management tools, including Veeva CTMS, eTMF, Study Startup, and Site Connect, as standardized applications for IQVIA's clinical development projects. This strategic alignment is designed to streamline processes and improve the overall speed of clinical trials.The partnership initially began in August 2025
A stack of clinical trial documents with a pen on a desk

Oct 13, 2026

WCG unveils AI-powered solution to accelerate clinical trial kickoffs

WCG has introduced Activation Intelligence, an AI-driven solution aimed at expediting the startup of clinical trials.This innovative program is designed to streamline the study activation process by automating the extraction and validation of information, which can then be reused across various workflows. In its early access phase, Activation Intelligence reportedly saved initial users over 20 hours of manual review per study, while ensuring transparency in the data utilized. This tool is part o
An open notebook and pen in a research office

Oct 10, 2026

AI Reads the Trials: LLM Framework Speeds Systematic Reviews of Digital Health RCTs

A recent study highlights the potential of large language models (LLMs) in expediting systematic reviews of randomized controlled trials (RCTs) focused on digital health technologies. Conducted by researchers led by Taylor B. Harrison and Dian Hu, the research introduces a retrieval-to-abstraction framework that utilizes pretrained LLMs to streamline the review process without requiring task-specific fine-tuning.The study addresses a critical need in the fast-evolving field of digital health, wh
Press release cover image

Oct 9, 2026

Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial

Dutch Cardiovascular Investigator Network (WCN) Leads European Enrollment in Phase 3 Study Evaluating Etripamil Nasal Spray for AFib-RVRMONTREAL and CHARLOTTE, N.C., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that the first European patient has been enrolled in ReVeRA-301, its ongoing Phase 3 pivotal trial evaluating etripami
Press release cover image

Oct 9, 2026

Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences

VANCOUVER, British Columbia, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today is pleased to announce that three abstracts related to Company’s ongoing Phase 1b/2 RESOLVE trial of EP-104GI for the treatment of eosinophilic esophagitis
Press release cover image

Oct 8, 2026

Verana Health and Bitfount Collaborate to Simplify Prescreening for Ophthalmic Clinical Trials

Multimodal approach combining ophthalmic imaging and EHR data improves speed and accuracy of identifying eligible patients for studiesSAN FRANCISCO, Oct. 8, 2026 /PRNewswire/ -- Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), has announced a new partnership with Bitfount, an on-premise federated AI analysis platform. The collaboration aims to significantly improve and accelerate patient identification for oph
Press release cover image

Oct 8, 2026

CureMD Earns ISO/IEC 42001 Certification for Responsible AI as It Advances Agentic Care

Certification covers AI Scribe, AI Medical Coder, AI Patient Contact Center and Clinical TrialsNEW YORK, Oct. 8, 2026 /PRNewswire/ -- CureMD Healthcare today announced that its Artificial Intelligence Management System (AIMS) has been certified to ISO/IEC 42001:2023, the international standard for responsible AI management.The independent audit certified CureMD's AI governance processes across its full lifecycle, including risk and impact management, security, transparency, human oversight, inci
A test tube in a dimly lit lab, symbolizing clinical trials.

Oct 7, 2026

ARPA-H unveils Surpass program to accelerate and expand clinical trials

The U.S. Department of Health and Human Services (HHS) has launched the Surpass program, aiming to revolutionize clinical trials by addressing existing barriers and enhancing trial design and execution.Announced on September 30, Surpass—standing for simulation-augmented, real-time platform adaptive seamless trials—will be implemented through the Advanced Research Projects Agency for Health (ARPA-H). While specific details remain sparse, the initiative will utilize predictive computational models
A flat design of a data sheet with a checkmark representing clinical trial data consolidation.

Oct 7, 2026

London’s Cori Clinical raises €3.56 million to accelerate clinical trials and reduce delays

Cori Clinical, a London-based startup focused on streamlining clinical trials, has successfully secured €3.56 million ($4 million) in a Seed funding round led by Breega, with contributions from several other investors. This funding aims to enhance the company’s operational capacity, expand its team, and strengthen its regulatory and clinical intelligence capabilities.The startup, co-founded by Jorn Jansen Schoonhoven and Patricio Fernández, offers a platform designed to consolidate fragmented da
Press release cover image

Oct 7, 2026

GC Cell and QuantHealth Collaborate to Optimize Clinical Development of GCC2005

The partnership brings QuantHealth's simulation platform into GCC2005's clinical development program, marking the company's entry into the Korean life sciences marketTEL AVIV, Israel--(BUSINESS WIRE)--GC Cell, a leader in the cell and gene therapy (CGT) sector within the biopharmaceutical industry, and QuantHealth, the global leader in AI-powered clinical trial simulation, have announced a collaboration to bring a simulation-first approach to the design of upcoming clinical trials for GCC2005, G
A patient chart on a desk in a hospital office

Oct 6, 2026

Ochsner uses AI to widen clinical trial screening

Ochsner Health is leveraging artificial intelligence to enhance the efficiency of clinical trial patient screening, addressing longstanding challenges in patient recruitment across its extensive health system.The integration of AI aims to streamline the identification of eligible patients for clinical trials, significantly reducing the manual workload on clinical trial staff. Ochsner, the largest nonprofit health system in Louisiana and Mississippi, operates 47 hospitals and over 370 clinics. Th
Press release cover image

Oct 1, 2026

Advances in Digital Therapeutics and HoneyNaps AI Enhance Clinical Trial Efficiency

Supporting pharmaceutical, medical device, wellness, and research organizations in obtaining standardized sleep data Expanding the use of SOMNUM scoring technology to provide clinical analysis services tailored to each customer's research objectives AI Technologies Supporting Global Clinical Trials in Drug DevelopmentBOSTON, Oct. 1, 2026 /PRNewswire/ -- More pharmaceutical companies and research organizations are turning to HoneyNaps, an AI-based sleep health technology company, for objective an